1. Home
  2. TCRX vs RMBL Comparison

TCRX vs RMBL Comparison

Compare TCRX & RMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • RMBL
  • Stock Information
  • Founded
  • TCRX 2018
  • RMBL 2013
  • Country
  • TCRX United States
  • RMBL United States
  • Employees
  • TCRX N/A
  • RMBL N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • RMBL EDP Services
  • Sector
  • TCRX Health Care
  • RMBL Technology
  • Exchange
  • TCRX Nasdaq
  • RMBL Nasdaq
  • Market Cap
  • TCRX 90.5M
  • RMBL 90.1M
  • IPO Year
  • TCRX 2021
  • RMBL N/A
  • Fundamental
  • Price
  • TCRX $1.27
  • RMBL $2.25
  • Analyst Decision
  • TCRX Strong Buy
  • RMBL Hold
  • Analyst Count
  • TCRX 7
  • RMBL 4
  • Target Price
  • TCRX $9.86
  • RMBL $4.50
  • AVG Volume (30 Days)
  • TCRX 389.5K
  • RMBL 102.5K
  • Earning Date
  • TCRX 05-06-2025
  • RMBL 05-07-2025
  • Dividend Yield
  • TCRX N/A
  • RMBL N/A
  • EPS Growth
  • TCRX N/A
  • RMBL N/A
  • EPS
  • TCRX N/A
  • RMBL N/A
  • Revenue
  • TCRX $4,421,000.00
  • RMBL $1,146,100,000.00
  • Revenue This Year
  • TCRX $47.30
  • RMBL N/A
  • Revenue Next Year
  • TCRX $74.30
  • RMBL $8.25
  • P/E Ratio
  • TCRX N/A
  • RMBL N/A
  • Revenue Growth
  • TCRX N/A
  • RMBL N/A
  • 52 Week Low
  • TCRX $1.02
  • RMBL $1.95
  • 52 Week High
  • TCRX $9.69
  • RMBL $7.06
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 37.62
  • RMBL 38.05
  • Support Level
  • TCRX $1.32
  • RMBL $2.46
  • Resistance Level
  • TCRX $1.65
  • RMBL $2.84
  • Average True Range (ATR)
  • TCRX 0.12
  • RMBL 0.20
  • MACD
  • TCRX -0.02
  • RMBL 0.02
  • Stochastic Oscillator
  • TCRX 0.00
  • RMBL 24.36

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About RMBL RumbleOn Inc. Class B

RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.

Share on Social Networks: